For Early-Stage Life Sciences CEOs
Where Life Science CEOs
Become Investable
A sprint-based execution platform where Life Sciences CEOs build leadership, execution discipline, and investor readiness through applied progress — not pitch decks.
CEO360 for CEOs
The Reality:
Great Science Just
Isn’t Enough
Most life science startups stall before institutional investment — not because the science fails, but because execution, leadership, and capital readiness
fall short under scrutiny.
CEOs often navigate fundraising, regulation, commercialization, and manufacturing challenges alone.
CEO360 is here to change that.
CEOs To Date
Cohorts to Date
CEOs Funded
What’s Makes CEO360 Different?
Not an Accelerator.
CEO360 Builds
Investable CEOs
CEO360 differs from typical startup programs by focusing on CEOs already leading companies and guiding them through a 12-month execution journey centered on investor readiness and disciplined value creation.
|
Typical Startup Programs |
CEO360 |
|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CEO360 - How It Works
How It Works:
12-Month Program
CEOs move through four structured execution sprints focused
on what investors actually evaluate:
- Leadership & governance maturity
- Technical and regulatory readiness
- Defensibility and risk clarity
- Capital and commercialization discipline
- Execution replaces theory.
CEO360 Cohorts
CEO360 2026 San Diego Life Sciences Cohorts
Three Important
Life Sciences Categories
Small Molecule
Categories Served
- Oncology therapeutics
- CNS and neurological treatments
- Rare disease therapeutics
- Immunology and inflammation programs
- Metabolic and endocrine therapies
- Infectious disease treatments
- Targeted small molecule platforms
- AI-enabled drug discovery programs
Large Molecule
Categories Served
Monoclonal antibody therapeutics
Bispecific & Multi-specific antibodies
Protein & Peptide therapeutics
Cell & Gene Therapy platforms
Engineered Biologics platforms
Immunotherapy Technologies
Biologics Platform Technologies
Medical Devices
- Implants
- Therapeutic devices
- Wearables and Monitoring technologies
- Connected care platforms
- Surgical & Interventional
- SAMD
- AI and Agentic Tools
Diagnostics
- Molecular diagnostic platforms
- Imaging and detection technologies
- Point-of-care diagnostic systems
Research & Clinical Tools
- Laboratory automation systems
- Drug discovery instrumentation
- Clinical workflow technologies
- Data and analysis platforms
About CEO360
Why CEO360? It's About Our Culture.
Serious Work
Human Environment
Peer-to-Peer
Accountability
Transformation
Culture of Mutual Support
CEO360 is a confidential, peer-driven environment where CEOs can be honest, learn, and solve real problems together. No selling. No competition in the room. We have a strong, supportive culture and we also weed out those who don’t fit. Mutual support is in our core DNA.
Responsibility for Results
We hold each other accountable. We believe in each other. We make it fun. No ego contests. No pretending. We stress balance. CEO360 are just operators helping fellow operators succeed in all aspects of their lives—business, health and family.
Founder To Investable CEO
A strong partnership between CEOs and VCs is critical. With the amazing, innovative science, our CEOs might just save the world. Solutions that will transform healthcare and improve the lives of patients. We help build the future leaders that VCs can trust.
CEO360 For VCs
VC Investors Refer CEOs and Then Return Quarterly
The CEO360
VC Investor Model
VC Refers CEO
CEO360 Sprints
Quarterly Check-Ins
"Passed Over" CEOs
Investors now have a way to help CEOs that are close but were passed over for an investment at this time. VCs often identify areas that need to be strengthened prior to funding. In fact, 60% of the time VCs pass during the due diligence process.
Tailored Program
CEO360 works closely with VC investors to understand the areas of concern. Through. the CEO360 sprint process we focus and address key areas. The goal is to derisk the investment opportunity for the VC and secure funding for the CEO.
VC Remains In the Loop
VCs return every 90 days to observe execution progress of the entire cohort. Conviction builds through visible improvement. Investors see progress. CEOs have clear direction and focus. Investability increases. This becomes a win-win scenario for all.
CEO360 For Partners
CEO360 trusted advisor partners support CEOs
moving from scientific promise to investability.
Why Our Partners
Support CEO360
CEO Connections
Better Biz Dev Model
Ecosystem Support
Helping CEOs Become Investable
Early exposure to emerging companies and leadership teams. Relationship development with CEOs before financing and M&A processes accelerate.
Expertise? Yes. Selling? No.
The right trusted advisors are critical to the future success of a scaling Life Sciences company. Demonstrating value and building trust is far better than tired biz dev tactics.
Long-Term Ecosystem Focus
Innovation visibility plus engagement with VCs and company leadership provides CEO360 partners a seat at the table in the ecosystem—now and in the future.
CEO360 For CEOs
Where Scientists Become CEOs Investors Believe In
The Moment When
The Lights Come On.
First, founders struggle, and realize they
can’t clearly explain it.
The value of their company.
Then, after presenting again and again, something changes. The timid presenter disappears.
The leader steps forward.
They stop reading slides. They start leading conversations.
They effortlessly handle tough questions.
They command the room.
The science didn’t change,
the CEO changed.
And the investors see it too.
That’s when funding happens.
That’s when companies move forward.
And that transformation
is why CEO360 exists.
CEO360 Peer-to-Peer Life Sciences Cohorts
From Isolation
To Collaboration
Going It Alone
Add Peer CEOs
Add Ecosystem
Lonely at the Top
Many life sciences founders carry the future of their company, employees, and patients alone. Decisions feel heavier, risks feel personal, and uncertainty constant. CEO360 exists so breakthrough leaders gain trusted peers beside them — and remember they don’t have to carry it alone.
Supported by Leaders Like You
CEO360 surrounds founders with peers who understand the pressure of turning science into companies. Isolation gives way to shared experience, sharper decisions, and renewed confidence as CEOs discover others facing — and overcoming — the same challenges together.
Part of a Thriving Ecosystem
CEO360 places founders inside a powerful ecosystem of investors, advisors, and partners who want companies to succeed. Momentum builds, doors open, and CEOs move forward knowing they belong to a community helping breakthrough science reach patients.
Building a Company Investors Trust
Requires a Shift in Focus
From Scientist
To Investable CEO
Focus on Science
Focus on Fundraising
Focus on Growth
Scientific Discovery & Validation
Early success is built on scientific discovery.
Founders prove the biology, validate the hypothesis, and generate data that shows real potential. But strong science alone doesn’t secure capital or build companies.
Investor Confidence & Credibility
Investors don’t just fund ideas — they fund leaders capable of navigating risk, governance, and execution. This stage demands narrative clarity, investor confidence, and the discipline to withstand scrutiny under diligence.
Scaling Leadership & Execution
Once funded, leadership demands change again. Teams expand, boards mature, and decisions carry real consequences. Sustainable growth requires CEOs who can the business without losing scientific integrity.